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Summary
A hypothesis that accounts for most of the available literature on insulin-stimulated GLUT4 translocation is that insulin
action controls the access of GLUT4 vesicles to a constitutively active plasma-membrane fusion process. However, using
an in vitro fusion assay, we show here that fusion is not constitutively active. Instead, the rate of fusion activity is stim-
ulated 8-fold by insulin. Both the magnitude and time course of stimulated in vitro fusion recapitulate the cellular insulin
response. Fusion is cell cytoplasm and SNARE dependent but does not require cell cytoskeleton. Furthermore, insulin
activation of the plasma-membrane fraction of the fusion reaction is the essential step in regulation. Akt from the cyto-
plasm fraction is required for fusion. However, the participation of Akt in the stimulation of in vitro fusion is dependent on
its in vitro recruitment onto the insulin-activated plasma membrane.Introduction
Insulin action on peripheral tissues including fat, heart, and
skeletal muscle leads to increased glucose transport, a pro-
cess essential for maintenance of metabolic processes that are
intricately dependent on the supply of glucose. The basis for
this action lies in the increased translocation of GLUT4-con-
taining vesicles from an intracellular reservoir compartment
and ultimately exposure of the GLUT4 at the cell surface where
it facilitates transport. Kinetic studies have identified that
GLUT4 traffics through multiple intracellular compartments in-
volving endosomes, the trans-Golgi network (TGN), and a spe-
cialized compartment in which GLUT4 is enriched (Slot et al.,
1991; Ramm et al., 2000; Bryant et al., 2002), and it is the
exocytosis process that is stimulated by insulin (Satoh et al.,
1993; Yang and Holman, 1993). However, the site of insulin
action along the exocytic pathway is unknown and potentially
could involve increased release or budding of vesicles from tu-
bular vesicular structures (Karylowski et al., 2004; Watson et
al., 2004), increased movements of vesicles along microtu-
bules (Bose et al., 2002; Semiz et al., 2003), increased transit
through cortical actin near the cell surface (Tong et al., 2001;
Chunqiu and Pessin, 2003), increased docking and then fusion
of vesicles at the plasma membrane (Satoh et al., 1993; Bryant
et al., 2002; Bose et al., 2004), and then possibly stimulation
of catalytic activity of plasma-membrane-inserted transporters
(Sweeney et al., 2004).
Likewise, although the early steps in insulin signaling that
converge on the GLUT4-trafficking process have been iden-
tified as PI 3-kinase and Akt (Holman and Kasuga, 1997; Czech
and Corvera, 1999; Bae et al., 2003; Jiang et al., 2003), the
downstream mediators of these stimulated activities that lead
to convergence with GLUT4-trafficking steps have also been
difficult to identify. There are many insulin-regulated Akt sub-
strates (Sano et al., 2003; Berwick et al., 2004; Goncharova et
al., 2004; Gridley et al., 2005) that could potentially be involved,
and further clarification of their roles could follow from identifi-CELL METABOLISM : SEPTEMBER 2005 · VOL. 2 · COPYRIGHT © 2005cation of the site in GLUT4 trafficking at which signaling con-
verges. Insulin-stimulated but PI 3-kinase-independent steps
in GLUT4 trafficking have also been described (Baumann et al.,
2000; Inoue et al., 2003; Kanda et al., 2005), but whether these
steps are rate limiting for translocation is incompletely re-
solved.
To further the resolution of the key regulated step, we have
developed an in vitro fusion reaction in which GLUT4 vesicles
are immunoisolated and fused with reconstituted plasma mem-
brane in the presence of cell cytoplasm. The separate analysis
of this partial reaction in the exocytic limb of the translocation
sequence allows direct analysis of the extent to which fusion
is insulin stimulated. A hypothesis that accounts for most of the
available literature on insulin-stimulated GLUT4 translocation is
that insulin action controls the access of GLUT4 vesicles to a
constitutively active plasma-membrane fusion process. How-
ever, using the in vitro fusion assay, we show here that this is
not the case. Remarkably, the magnitude and time course for
insulin’s action on glucose transport is fully recapitulated in the
vesicle fusion reaction.
Cell-free reconstitution of vesicle fusion reactions have many
advantages for studying cell biology processes, as the sepa-
rate components on the fusion reaction can be separately ma-
nipulated and combined. This approach has been very power-
fully pioneered and applied to the study of intracellular vesicle
homotypic and heterotypic membrane fusion (Beckers et al.,
1989; Rothman and Sollner, 1997), but the application to the
fusion of intracellular vesicles with the limiting plasma mem-
brane has been more difficult to achieve (Avery et al., 1999).
Our novel approach to the study of the heterotypic fusion of
intracellular vesicles with reconstituted plasma membrane is
also likely to be a powerful generally applicable technique. The
cell-free approach is particularly powerful in studying insulin-
regulated fusion as separate mixing of vesicles containing in-
sulin-activated and nonactivated components is feasible, as
we demonstrate here. With this approach, we have attempted
to distinguish whether insulin action leads to activation ofELSEVIER INC. DOI 10.1016/j.cmet.2005.08.007 179
A R T I C L EGLUT4 vesicles, activation of components of the cytoplasm
fraction, or activation of components of the plasma-membrane
fraction. Our data reveal that it is the activation of that plasma-
membrane fraction that is the key regulated step in the stimula-
tion of fusion.
Results
Reconstitution of GLUT4 vesicle fusion
with plasma membrane
Although membrane fusion can be studied by the merging of
membrane lipid markers, it is best studied in assays in which
vesicle content mixing occurs (Weber et al., 1998; Schuette
et al., 2004). This is because lipid mixing can occur between
hemifused vesicles (Reese et al., 2005). Only full fusion results
in content mixing. To detect content mixing in the fusion reac-
tion, we employed biotin-streptavidin technology and TR-FRET
to detect a fusion complex between a FRET pair that was
formed in the fusion reaction (Figure 1A). Therefore, it was nec-
essary to introduce the FRET pair into separate vesicles during
their preparation. The procedure involved the separate prepa-
ration of GLUT4 vesicles, plasma membrane, and cell cytosolFigure 1. In vitro fusion of GLUT4 vesicles with reconstituted plasma membrane
A) In the fusion assay, GLUT4 vesicles containing DyLight647 streptavidin-tagged GLUT4 were mixed with PM liposomes containing biotinylated Eu(TMT) in the
presence of cytosol. The transmembrane GLUT4 is shown as the green symbol; the tetrameric streptavidin is shown as the multisite red symbol); the biotin Eu(TMT)
is shown as the yellow symbol. To terminate the fusion reaction, triton X100 was added. The solubilized samples were then analyzed for the presence of a GLUT4-
streptavidin-DyLight647-biotin-Eu-TMT complex by TR-FRET (with excitation at 340 nm and emission at 670 nm). No FRET occurs from the unreacted biotin Eu(TMT).
B) Structures of the GP15 used to biotin tag GLUT4 and the biotin-Eu(TMT) complex that was incorporated into the PM liposomes.180from rat adipocytes that were either in the basal state or in an
insulin-stimulated state.
In order to isolate and then harvest GLUT4 vesicles in a func-
tional state, new methodology that utilized a maltose binding
protein-protein A (MBP-pa) construct was developed. The idea
here was that (unlike detergent elutions normally employed for
release of immunopurified GLUT4 vesicles) a maltose elution
of vesicles would not be damaging to vesicle content. GLUT4
was initially tagged at the cell surface with the biotin photoaf-
finity label GP15 (Figure 1B) and DyLight 647-streptavidin, and
then internalized. Vesicles from homogenized cell post-high-
density microsome supernatant were then applied directly with
an amylose resin column to which a MBP-pa recombinant pro-
tein and an anti-GLUT4 antibody had been prebound. GLUT4
vesicles were then eluted with maltose. We found that 60%–
70% of the GLUT4 from intracellular membrane fractions from
rat adipocytes bound to the column, and of this, 70% could
be released with maltose (Figure 2A). Most likely, the efficien-
cies of recovery are unrelated to vesicle heterogeneity, but this
cannot be completely excluded. The GLUT4 vesicle population
from rat adipocytes is much more homogeneous than that from
3T3-L1 cells (Malide et al., 1997; Lizunov et al., 2005). We haveCELL METABOLISM : SEPTEMBER 2005
In vitro GLUT4 vesicle fusionFigure 2. New methodologies used for preparation of fusion competent GLUT4
vesicles and plasma membrane
A) GLUT4 vesicles were immunoisolated from the post-high-density microsome
supernatant (pHDM) of homogenized adipose cells. GLUT4 vesicles in this frac-
tion were bound to amylose resin prebound with MBP-pa and GLUT4 antibody.
The amounts of GLUT4 remaining in the supernatant (IPS), selectively eluted with
20 mM maltose (6 fractions), and remaining on amylose beads were determined.
A sheep GLUT4 antibody was used to detect GLUT4 on the blots. This produced
only minimal interference from the rabbit GLUT4 IgG used to isolate the vesicles.
The elution of MBP-pa was also followed using this antibody.
B) Plasma membranes (PM) from basal (B) and insulin-treated (Ins) adipose cells
were reconstituted into phosphatidylcholine liposomes (PM liposomes) and the
recoveries of GLUT4, and the t-SNAREs Syntaxin4 and SNAP23 were deter-
mined.found (unpublished data) that, when using homogenates of rat
adipose cells, only a single population of GLUT4 vesicles can
be resolved on iodixanol gradients. By contrast, this procedure
separates two populations of vesicles when applied to 3T3-L1
homogenates (Hashiramoto and James, 2000). There was no
detectable depletion of GLUT1 from the post-high-density
microsome supernatant by the amylose column, and no
GLUT1 was eluted with maltose (unpublished data). The levels
of GLUT1 in the intracellular compartment of rat adipose cells
are less than 10% of the levels of GLUT4 (Holman et al., 1990).
This contrasts with 3T3-L1 cells in which the ratio of GLUT1:
GLUT4 is 1:1 or greater (Calderhead et al., 1990; Palfreyman
et al., 1992). Even if a very small amount of GLUT1 were in
GLUT4 vesicles, we do not think this detracts from the use of
the method as any heterogeneity in the vesicle population re-
flects the heterogeneity of the intact cell.
The content mixing approach requires the encapsulation of
material in the plasma membrane. However, we have found
that plasma membrane alone could not be induced to encap-
sulate ligands. We therefore employed an approach that in-
volved reconstitution of plasma membrane in exogenous phos-
pholipids. We reconstituted plasma membrane by using an
adaptation of a previously described method (Suzuki and
Kono, 1980; Kono, 1983; Schurmann et al., 1989). The biotin-
europium (TMT) ligand (Figure 1B) was incorporated into the
reconstituted plasma membrane vesicles at this stage. Follow-
ing this reconstitution step, the PM liposomes were purified by
flotation on Histodenz gradients (Weber et al., 1998).
To investigate whether the liposomes were permeable to
small molecules, the capacity of BODIPY-FL-avidin fluores-
cence to strongly increase on binding of a biotinylated ligand
(Emans et al., 1995) was utilized. For this permeability test, the
liposomes were prepared with 100 g/ml BODIPY-FL-neutravi-CELL METABOLISM : SEPTEMBER 2005din instead of Biotin-Eu (TMT). The maximum fluorescence en-
hancement was determined with 40 nM BODIPY-FL-neutravi-
din in the absence of liposomes and using 40–200 nM biocytin.
40 nM BODIPY-FL-avidin-loaded liposomes were then incu-
bated with 40–200 nM biocytin or biotin methyl ester (mem-
brane-permeable reagent). The BODIPY-FL fluorescence re-
mained low (<4% of maximum) in the presence of biocytin but
increased in the presence of biotin methyl ester (57% of maxi-
mum). Lysing the liposomes with 0.2% triton X100 prior to the
biocytin addition also resulted in BODIPY-FL fluorescence en-
hancement (79% of maximum). These data confirmed that the
liposomes were impermeable to biocytin under the conditions
used in the fusion assay.
We found that 80% of plasma-membrane GLUT4 and of syn-
taxin4 and 60% of SNAP23 were recovered in the reconstituted
liposomes (Figure 2B). The GLUT4 level was higher in the
membranes from insulin treated cells but the levels of recov-
ered syntaxin4 and SNAP23 were not influenced by insulin
treatment.
Properties of the vesicle fusion reaction
The GLUT4 vesicle fusion process, as determined in intact cell
studies, is known to be dependent on the v-SNARE protein
VAMP2 and the t-SNAREs syntaxin4 and SNAP23 (Cheatham
et al., 1996; Foran et al., 1999; Bryant et al., 2002). We there-
fore sought to determine whether the in vitro system showed
an equivalent SNARE dependency. The in vitro fusion process
was confirmed as being SNARE dependent as treatment of the
isolated GLUT4 vesicles with Botulinum Light Chain/B prote-
ase (BoLC/B) prior to fusion resulted in cleavage of the GLUT4
vesicle SNARE, VAMP2 (Figure 3A) and to a complete block-
age of fusion (Figure 3B).
Much accumulated data on GLUT4 trafficking has implicated
the involvement of cytoskeletal proteins including microtubules
and actin. We therefore tested whether the fusion step, a partial
step in translocation, was altered by the actin depolymerising
drug, latrunculin B. We found that 250 nM latrunculin B did not
inhibit the fusion reaction (Figure 3B), although this concentra-
tion is known to inhibit GLUT4 translocation in cells (Khayat et
al., 2000). These data suggest that cytoskeletal components
and actin are not involved in facilitating fusion and that the
fusion step in translocation can be separated from the steps in
translocation that involve the cytoskeleton.
We found that cell cytoplasm from insulin-treated cells sup-
ported fusion in a concentration-dependent manner (Figure
3C). This suggested that factors from cytoplasm were required
to facilitate and drive fusion and that preactivated plasma
membrane alone was insufficient.
Insulin regulation of fusion
The time course for fusion (Figure 4A) was remarkably similar
to the time course for insulin stimulation of glucose transport
in intact cells. The first order rate constant was 14-fold faster
using plasma-membrane liposomes from insulin-treated cells
compared with basal cells. The rate constant was increased
from 0.015 ± 0.005 to 0.213 ± 0.027 min-1 (from five separate
experiments). We determined the extent of fusion by compar-
ing the end points of the time courses with the total amount of
complex and FRET signal that was produced when the assay
components were treated with detergent in the absence of bio-
cytin. Under these conditions all the DyLight647 streptavidin181
A R T I C L EFigure 3. GLUT4 vesicle fusion is dependent on SNAREs and cytosol but not
actin
A) GLUT4 vesicles were pretreated with 10 nM botulinum light chain/B protease
(BoLC/B) for 60 min and cleavage of VAMP2 was determined by western blotting.
B) Fusion activity using GLUT4 vesicles with (BoLC/B) and without (control) pro-
tease pretreatment was determined. 250 nM Latrunculin B did not inhibit fusion.
C) GLUT4 vesicle fusion activity was determined using PM liposomes from insu-
lin-treated cells. Cytosol was prepared from a concentrated cell suspension
(>70% cytocrit) of insulin-treated adipose cells. The concentrated cytoplasm was
diluted by a half and a quarter with a corresponding decrease in fusion activity.
Data are mean and SEM from three experiments in each case; * indicates p <
0.05 versus control.182Figure 4. Fusion activity is dependent on insulin-treated plasma membrane
A) Time courses for fusion were determined using components from either basal
(B) or insulin treated (C) cells. The curves were derived from fitting first-order
rate constants. The rate constant were 0.015 ± 0.005 and 0.213 ± 0.027 min−1
for basal and insulin samples, respectively. Results are the mean and SEM from
five experiments.
B) GLUT4 vesicle fusion activity was determined using cytosol and PM lipo-
somes from either basal (Bas) or insulin-treated cells (Ins). A 7- to 9-fold differ-
ence in fusion activity was observed when comparing all basal and all insulin
components. * indicates p < 0.05 versus Bas cyt, Bas PM. Data are mean and
SEM from three to ten experiments.binds biotinylated Europium(TMT), as there was no competing
ligand and no intact membranes to limit their interaction. After
30 min of fusion for the insulin samples, and after 60 min of
fusion for the basal samples, the FRET signals were 95 ± 11%
and 77 ± 9% of the maximum (from three separate experi-
ments). These end point values are consistent with the esti-
mated rate constants and suggest that it is the rate rather than
the extent of fusion that is stimulated by insulin. Although all
the contents of the GLUT4 vesicles used in the assay partici-
pate in fusion, we cannot eliminate the possibility that the cells
contain a population of additional GLUT4 vesicles that might
behave differently. This is because, although fusion is close to
100% efficient, not all the cell GLUT4 vesicles were recovered
using the MBP-pa affinity isolation technique (see above).
Mixing insulin-treated cytoplasm and insulin-treated plasma-
membrane liposomes produces an 8-fold higher rate of fusion
than mixing basal cytoplasm and basal liposomes at 37°C (Fig-
ure 4B). The single 5 min time point used for these assays mayhave led to an underestimate of the magnitude of the insulin
response as the fusion activity for the insulin treated fractions
had reached 60%–70% of the maximum within this time. Nev-
ertheless, the use of this single time point assay allows com-
parisons between assay conditions. Surprisingly we found that
insulin-treated plasma-membrane liposomes were able to sup-
port fusion in the presence of basal cytoplasm. These data
suggest that insulin-stimulated plasma-membrane compo-
nents were capable of recruiting factors from the cytoplasm
that led to activation of fusion. By contrast, basal plasma mem-
brane was not able to support rapid fusion even in the pres-
ence of cytoplasm from insulin-treated cells (Figure 4B).
Convergence of insulin signaling
at the vesicle fusion reaction
Early signaling events that lead to stimulated glucose transport
are now known to include activation of PI 3-kinase (Hara et al.,
1994; Czech and Corvera, 1999) which leads to downstream
activation of Akt (Foran et al., 1999; Whiteman et al., 2002;
Jiang et al., 2003; Murata et al., 2003) but the sites of con-CELL METABOLISM : SEPTEMBER 2005
In vitro GLUT4 vesicle fusionvergence of signaling with GLUT4 trafficking processes have
been difficult to resolve.
To resolve whether insulin-stimulated glucose transport was
rate determined by the PI 3-kinase step we compared the dose
responses for wortmannin inhibition of glucose transport and
GLUT4 exocytosis (Figures 5A and 5B). Both transport and ex-
ocytosis were inhibited with an IC50 of approximately 10 nM.
This dose response was markedly well matched by the corre-
sponding decrease in phospho-Akt levels (Figures 5A and 5B).
In an attempt to determine whether the PI 3-kinase require-
ment for fusion was through its activation in the cytosol or the
plasma-membrane fraction, we prepared fractions for the fu-
sion assay from wortmannin treated cells. No inhibition of fu-
sion was observed using cytosol from wortmannin-treated
cells. This is perhaps not surprising as the effects of wortman-
nin are rapidly lost as the reagent is inactivated by water and
amines over long incubations (unpublished data and see Meth-
ods section). Of particular interest however was the observa-
tion (Figure 5C), that a plasma-membrane fraction from wort-
mannin-treated cells was inactive in the fusion assay. This was
consistent with earlier observations and interpretations that
suggested that the assay fraction that was key to the regulation
of fusion activity was the plasma membrane.
We also tested whether wortmannin could inhibit fusion
when added to the reconstituted system and after the cellular
insulin stimulation. Fusion was blocked completely at 100 nM
and by approximately half at 10 nM (Figure 5D). The wortman-
nin inhibition data collectively suggest that the fusion rate had
the same PI 3-kinase dependence as the subsequent steps
and therefore rate limited these subsequent steps.
Requirement of Akt in the fusion reaction
To establish whether Akt was required for the vesicle fusion
reaction we carried out a procedure to deplete Akt from the
cytoplasm. Immunodepletion of Akt1 from the cytoplasm frac-
tion alone reduced fusion activity by z 50% while depletion of
both Akt1 and Akt2 reduced the fusion activity by 80% (Figure
6B). Some residual fusion occurred even though the depletion
procedures reduced the total amounts Akt1 and Akt2 to less
than 7% and 3% respectively of their initial levels (Figure 6A).
This residual fusion activity may have been due to some low
level of activated Akt that was already recruited to the plasma
membrane, although we were unable to detect this (Figures 6C
and 7). Alternatively the residual fusion activity may have been
due to the presence of an Akt isoform that was not removed
by our depletion protocol. These data correspond closely with
data obtained in intact 3T3-L1 adipocytes using siRNA di-
rected against these two Akt isoforms (Jiang et al., 2003).
We were able to detect recruitment of both Akt1 and Akt2
from cytosol onto liposomes under the conditions of the fusion
reaction (but in the absence of GLUT4 vesicles). The levels of
recruitment onto liposomes prepared from the insulin-treated
samples were significantly higher than from basal samples
(Figure 6C). Similarly when cells were pretreated with the PI
3-kinase inhibitor wortmannin before insulin, the levels of Akt
subsequently recruited onto isolated liposomes were the same
as those recruited from the liposomes from basal cells (Figure
6C). These data are consistent with the carry over of endoge-
nous lipid, including cellular PIP3, into the isolated plasma-
membrane fraction of the fusion reaction. Such carry over ofCELL METABOLISM : SEPTEMBER 2005Figure 5. PI 3-kinase-dependent signaling to the multiple steps involved in
GLUT4 exocytosis
A) Wortmannin (Wtm) at the indicated concentrations was used to inhibit glucose
transport activity (C) and GLUT4 exocytosis (,) and phosphorylation of Akt (B).
Transport activity was determined using 3-O-methyl-D-glucose as tracer and
GLUT4 exocytosis was determined by measuring the extent to which internalized
biotin-tagged GLUT4 reemerged at the cell surface. Data are mean and SEM
from three experiments for transport and exocytosis and mean of two experi-
ments for Akt phosphorylation.
B) Top, panels are from a representative blot of GLUT4 exocytosis in basal cells
(B) or insulin-treated cells (Ins) in the presence of the indicated concentrations of
wortmannin. In the absence of wortmannin, GLUT4 is returned to the surface
rapidly and is quenched by extracellular avidin (low GLUT4 signal on the blot).
At high wortmannin concentrations, GLUT4 is returned to the surface slowly at a
rate comparable with that of basal cells. The bottom panels are from a represen-
tative blot of Akt phosphorylation at threonine308 at the indicated concentrations
of wortmannin.
C) Fusion activity was measured after treatment of intact cells with insulin in the
absence or presence with 100 nM wortmannin and subsequent isolation of sepa-
rate plasma membrane (Ins PM, Wtm PM) and cytosol (Ins cyt, Wtm cyt) frac-
tions, respectively. These fractions were then mixed as indicated to determine
whether inhibitory activity was retained in either the plasma membrane or the
cytosol fraction. Results are the mean and SEM from three experiments.
D) GLUT4 vesicle fusion activity with insulin PM liposomes was inhibited by 10
nM and 100 nM wortmannin added to reaction components for 10 min at 18°C
and present during the fusion reaction. Data are mean and SEM from three ex-
periments.lipid has been previously reported for other membrane recon-
stitution systems (Baldwin and Lienhard, 1989).
When added to the isolated plasma-membrane liposomes
and cytoplasm fractions separately, no wortmannin effect on183
A R T I C L EFigure 6. Cytoplasmic Akt is required for GLUT4 vesicle fusion and is recruited
onto lipsomes
A) Akt1 was depleted from cytoplasm of insulin-stimulated cells using immobi-
lized Akt1 antibody clone 5G3 (Cell Signaling Technology). No depletion was
observed with an irrelevant IgG control. Very little depletion of Akt2 occurred
using this antibody. Successive use of anti-Akt1 antibody and anti-Akt2 antibody
clone AW114 (Upstate) depleted the cytoplasm of both Akt1 and Akt2.
B) Fusion activity of GLUT4 vesicles with insulin PM liposomes was determined
using cytoplasm from the IgG control and following Akt1 and Akt2 depletion.
Data are mean and SEM from three experiments. * indicates p < 0.05 versus
control.
C) PM liposomes prepared from basal (B) or insulin-treated cells (Ins) or cells
treated with 200 nM wortmannin (Wtm) and then insulin were incubated for 15
min at 37°C in the fusion buffer in the absence (right panels) and presence (left
panels) of the respective cytosol but without the GLUT4 vesicles (which interfere
with the detection of the Akt). Following the incubations the liposomes were
reisolated and separately analyzed for the presence of associated Akt1 and Akt2.
Results are representative blots from two very similar experiments.184Figure 7. In vitro wortmannin treatment blocks phosphorylation of Akt on insulin-
stimulated PM liposomes
A) Treatment of separate cytosol and PM liposomes from basal (B) and insulin-
treated cells (I) with wortmannin (Wtm) at 100 nM at 37°C for 10 min did not alter
the levels of phosphothreonine 308 Akt.
B) The cytosol and PM liposome components of the fusion reaction were incu-
bated for 15 min at 37°C in the fusion buffer but without the GLUT4 vesicles
(which interfere with the detection of the Akt). The liposome and cytoplasm were
then reisolated and separately analyzed for the presence of threone308-phos-
phorylated Akt. Phosphothreonine308 Akt was increased in the liposome pellet
(comparing Figure 4A, right panels with Figure 4B, bottom left panels) and this
was blocked by the wortmannin treatment.
C) Quantification of in vitro Akt phosphorylation of Akt on PM liposomes. Data
are the mean and SEM from four experiments.Akt net phosphorylation was evident (Figure 7A). In the former
case the phospho-Akt on the plasma membrane was undetect-
able. In the later case the phospho-Akt remained high in the
insulin-stimulated cytoplasm as it had already been activated.
As a dynamic and continuous PI 3-kinase requirement for Akt
phosphorylation and for stimulation of fusion was possible, we
next examined whether the levels of phosphorylation of Akt
on the plasma-membrane liposomes were decreased by the
wortmannin treatment. Liposomes and cytosol were mixed
with the ATP regenerating system. We then observed increased
levels of phosphorylated Akt on the liposomes prepared from
insulin-treated cells and that there was a decrease in this phos-
phorylation following in vitro wortmannin treatment (Figures 7B
and 7C).
A de novo phosphorylation process can account for the ob-
served fusion using samples from insulin-treated plasma-mem-
brane liposomes and basal cytosol (Figure 4B). By contrast
preactivated and phosphorylated Akt was in abundance in the
cytosol from insulin-treated cells (Figure 7A) but this was insuf-
ficient to drive fusion of GLUT4 vesicles with basal plasma-
membrane liposomes (Figure 4B). These data suggested that
phosphorylated Akt in the cytoplasm alone was insufficient to




This study describes, for the first time, a direct demonstration
of hormone (in this case insulin) regulation of membrane fusion.
The in vitro approach provides an unequivocal evaluation of
the role of the fusion step as it represents a partial reaction in
the GLUT4 vesicle translocation process. Although several re-
cent microscopy studies on GLUT4 movement in cells have
suggested that a regulated fusion step is likely (van Dam et al.,
2005; Kanda et al., 2005; Lizunov et al., 2005), it is difficult to
interpret such studies as many factors before and after the fu-CELL METABOLISM : SEPTEMBER 2005
In vitro GLUT4 vesicle fusionsion step can influence the appearance of tagged-GLUT4 at
the cell surface. Although the use of TIRF microscopy (Lizunov
et al., 2005) has narrowed down the number of partial reactions
involved in the insulin stimulation of exocytosis, the interpreta-
tion of these microscopy images is equivocal because the net
incorporation of GLUT4 into the plasma membrane can be in-
terpreted as indicating an involvement of the cytoskeleton,
docking and fusion and endocytosis. In addition, fusion and
endocytosis may be tightly coupled and the location of the
membrane site at which these partial reactions occur may not
be distinct (Holroyd et al., 2002). The in vitro analysis of the
fusion reaction allows the fusion step to be studied in isolation
from any involvement of the cytoskeleton or the endocytosis
steps.
The present study on GLUT4 vesicle fusion has demon-
strated that the magnitude and time course of insulin stimula-
tion of fusion is comparable with its stimulatory effect on glu-
cose transport in target cells. Furthermore as the stimulation
of fusion has been shown to be dependent on PI 3-kinase and
on Akt activities, the study provides a direct identification of
the sites of action of these signaling intermediates. A particu-
larly useful feature of the in vitro approach is that it allows the
separate manipulation of the membrane fractions and compo-
nents involved in the fusion step. The GLUT4 vesicles used in
the fusion reaction are labeled and tagged by GP15 and strep-
tavidin and then internalized in the absence of insulin. Thus,
the vesicles obtained in this way represent GLUT4 vesicles in
the basal or nonstimulated state. The cytosol appears to be
important in providing components that stimulate fusion after
their recruitment to the plasma membrane. However, insulin-
activated cytosol alone is insufficient to facilitate fusion with
plasma-membrane liposomes prepared under basal condi-
tions. It follows that the insulin-regulated fraction is not the cy-
tosol or the GLUT4 vesicles. Instead the insulin-regulated frac-
tion is the plasma membrane. This conclusion is consistent
with several additional observations. These include the obser-
vations that plasma-membrane liposomes can support fusion
using basal cytosol and insulin-stimulated plasma-membrane
liposomes can recruit and then phosphorylate Akt from the
basal, signaling-inactive cytoplasm. The cell-free approach has
therefore led to a focus on the plasma-membrane fraction for
follow-up studies. Further studies will be required to fully iden-
tify the full range of components of the plasma membrane that
are preactivated by insulin treatment of cells.
Another useful feature of the in vitro fusion approach is that
selected proteins can be immunodepleted from the fusion re-
action. Using this approach we have found that Akt is required
for fusion. Furthermore, the initial insulin response, to generate
PIP3 to which PDK1 and Akt can be recruited, is carried
through in the reconstituted membranes. Akt itself is not car-
ried through on the liposomes but can be recruited onto the
activated liposomes in vitro. These data extend, to the in vitro
system, cellular studies that have shown that constitutively
active and membrane associated Akt stimulates GLUT4 trans-
location (Kohn et al., 1998). The Akt isoform specificity for the
fusion reaction is similar to that revealed using siRNA tech-
niques (Jiang et al., 2003) in that depletion of both Akt1 and
Akt2 is necessary for marked inhibition of translocation (as
measured in cells) and fusion (as measured in vitro). Our data
indicate somewhat more dependence on Akt1 as depletion of
this isoform alone reduces fusion by 50%. However, the de-CELL METABOLISM : SEPTEMBER 2005pleting antibody may not be completely specific for Akt1. In
principle it should also be possible to immunodeplete selected
proteins from the plasma-membrane liposomes, as these are
initially solubilized in octyl glucoside detergent and could be
manipulated at this solubilized membrane stage.
Linking signaling to vesicle fusion
The parallel dose response effects of wortmannin on glucose
transport activity and GP15 exocytosis suggest that there is no
activation of GLUT4 after it is exposed at the cell surface. The
GP15 labeling is carried out before the exocytosis assay so
that any differences in photolabel appearance at the cell sur-
face cannot be attributed to changes in transporter affinity for
the photolabel. Furthermore these experiments measure the
rates of movement which are independent of steady-state dis-
tribution level of GLUT4. Therefore these data suggest that any
activation of transport after the exposure of GLUT4 at the sur-
face, and after fusion, is not rate limiting.
It has recently been demonstrated that many of the substeps
in fusion, up to and including the hemifusion state, are revers-
ible and distinguishing between these steps is therefore prob-
lematic (Reese et al., 2005). However, previous studies have
shown that cosedimentation of GLUT4 vesicles with insulin-
stimulated plasma membrane is not wortmannin sensitive (In-
oue et al., 1999). This suggests that after the wortmannin treat-
ment the cosedimented fraction contains docked vesicles and
that docking may not be wortmannin sensitive. Studies on 3T3-
L1 cells (Hausdorff et al., 1999) have shown that the incorpora-
tion of GLUT4 into the plasma membrane as measured in iso-
lated lawns is somewhat less sensitive to PI 3-kinase inhibition
than the full incorporation of GLUT4 as detected by measure-
ments of transport activity. As this lawn procedure measures
tethered, docked and fused GLUT4 vesicles, one interpretation
of these findings is that the tethering/docking step is less de-
pendent on PI 3-kinase. In addition recent studies in 3T3-L1
cells have shown that partial inhibition of signaling, either by
inhibition of PI 3-kinase with LY294002 (Bose et al., 2004) or
by inhibition of Akt phosphorylation via a low temperature
block (van Dam et al., 2005) leads to the accumulation of teth-
ered/docked vesicles. Collectively these data suggest that the
wortmannin sensitive step lies beyond the tethering and dock-
ing steps. However, future studies addressing this issue in a
cell free system are warranted.
Our data suggest that it is the association of the Akt with the
liposomes that is the insulin-sensitive step in signaling that
leads to activation of fusion. The in vitro wortmannin effect on
Akt phosphorylation suggests a dynamic and continuous PI
3-kinase and phospho-Akt requirement for fusion. An activa-
tion of all the fusion components would have already occurred
in samples in which all components are from insulin-stimulated
cells. Therefore steps beyond the wortmannin-sensitive PI
3-kinase step might be expected to no longer require the con-
tinuous activation of PIP3 production. Our observation that
wortmannin still inhibits fusion under these conditions sug-
gests that there is turnover of the activated and phosphory-
lated form of Akt. This leads to the conclusion that Akt phos-
phorylation does not lead to a triggering mode of activation of
fusion but instead a continuous cycling of phosphorylated Akt
production is required to drive fusion. This may be similar to
the yeast system in which a phosphatase and a phosphoryla-185
A R T I C L Etion/dephosphorylation cycle control the activity of the SNARE
associated protein vps45 (Bryant and James, 2003).
Homotypic membrane fusion processes such as endosome/
endosome fusion reactions are known to be dependent on PI
3-kinases and are inhibited by wortmannin. It seems that the
PI 3-kinase-dependent step in this type of fusion is linked to
Rab activity (Jones et al., 1998; Lawe et al., 2001). Therefore
potential mediators of fusion include the Rab proteins. In this
context, a common theme in insulin action that appears to be
emerging is that many Akt substrates are small GTPase GAP
proteins (Sano et al., 2003; Gridley et al., 2005). These sub-
strates include AS160, AS250, TSC1/TSC2 etc. In each case
phosphorylation via Akt reduces GAP activity and therefore
leads to activation of the corresponding small G protein activ-
ity. It would be of interest to determine whether a protein of the
GAP type is a mediator of membrane fusion of GLUT4 vesicles.
A link between Rab proteins and fusion may be mediated by
Rab effectors that combine with the SNARE fusion apparatus
and its associated proteins such as Munc18c (Nielsen et al.,
2000; Bryant et al., 2002; Kanda et al., 2005).
Inhibited fusion may result in GLUT4 vesicle queuing
As the fusion step leads directly to GLUT4 becoming available
for transport, a low basal rate of fusion will rate limit and deter-
mine the overall rate of the translocation process. Several
studies have suggested that under conditions in which insulin
action is perturbed, some GLUT4 vesicles are released from
the intracellular reserve compartment and accumulate under
the plasma membrane but do not fuse with it. These studies
include the use of a low temperature block (Satoh et al., 1993;
van Dam et al., 2005), use of insulin counterregulatory treat-
ments with isoproterenol and cytosol acidification (Vannucci et
al., 1992; Yang et al., 2002a, 2002b), and inhibition or loss of
function of the SNARE-regulatory protein Munc18c (Thurmond
and Pessin, 2000; Kanda et al., 2005). One interpretation of
these findings is that insulin action on a separate release or
transit step involving the cytoskeleton may account for accu-
mulation of nonfused GLUT4 vesicles. (Thurmond and Pessin,
2000; Baumann et al., 2000; van Dam et al., 2005; Kanda et
al., 2005). However, cytoskeleton components are not directly
involved in fusion as we find no latrunculin B effect on fusion.
We find that the full cellular insulin response on glucose
transport is recapitulated in the magnitude, time course and
PI 3-kinase dependence of the fusion step. This leads us to
hypothesize that insulin regulation of fusion is not only limiting
the appearance of GLUT4 at the surface but is indirectly and
consequentially influencing the extent to which the internal re-
serves are emptied, and the extent to which vesicles are asso-
ciated with the cytoskeleton. This indirect effect could occur if
there is queuing for fusion and transit along microtubules. The
extent and location of queuing could then be dependent on
the extent of release of GLUT4 at the fusion site. Instead of
having a regulating role, the cytoskeletal proteins may have a
permissive role in allowing and facilitating access of GLUT4
vesicles to the plasma-membrane fusion apparatus (Bose et al.,
2004). Perturbation of cytoskeletal proteins including micro-
tubules and actin may block the insulin response in intact cells
since the translocation-facilitating function of these proteins
would be blocked. Such a queuing mechanism would be con-
sistent with the observation that low concentrations of insulin186lead to partial release of GLUT4 to the cell surface (Govers et
al., 2004).
The cell biology of GLUT4 trafficking is complex and many
issues and controversies have yet to be solved. Nevertheless,
the identification of fusion as the key regulated step in the
overall translocation process should facilitate further focus on
this topic. Cell biology approaches have identified much of the
machinery of membrane fusion (Bryant et al., 2002) and further
application of such approaches to the problem of insulin regu-
lation of cell glucose metabolism would be expected to be a
fruitful avenue of further research.
Experimental procedures
General methods
The biotin-TMT(Eu) complex was prepared by reacting the biotin-PEG
spacer (Hashimoto et al., 2001) with Eu(TMT)-isothiocyanate (Amersham
Biosciences). Sheep and rabbit polyclonal GLUT4 antibodies were raised
against a GLUT4 C-terminal peptide (Satoh et al., 1993). GLUT1 monoclonal
antibody was from Biogenesis. Akt1 and Akt-phosphothreonine308 anti-
bodies were from Cell Signaling Technology. Akt2 antibody was from Up-
state. Rabbit polyclonal antibodies to Syntaxin4 and SNAP23 were ob-
tained by using recombinant proteins as antigen. VAMP2 antibody was from
SYnaptic SYstems. Wortmannin was from Sigma or Calbiochem. It was
stored in low water content DMSO. The stock was diluted by adding buffer
to the DMSO solution gradually (to prevent precipitation of this hydrophobic
reagent). Diluted solutions of wortmannin were used immediately and were
not stored.
Preparation of maltose binding protein-protein A
The spa gene encoding for two and a half IgG binding sites of Staph. aureus
Protein A (Zueco and Boyd, 1992) was amplified by PCR from the pAX11
vector with primers BamHI-spa (5#-GGG GGA TCC CCA AGC TTA AAA
GAT GAC CC introducing a BamHI restriction site upstream of the spa gene)
and M13Uni. The PCR product was digested with Bam HI and Spe I and
ligated in pMBP-parallel2 plasmid (Sheffield et al., 1999). The resulting vec-
tor MBP-pa was used transformed into E. coli strain TB1. Bacterial lysate
was clarified by centrifugation and the resulting supernatant containing the
MBP-pa stored frozen at -70°C for further use. When required the MBP-pa
was purified by attachment to amylose resin.
Isolation of tagged GLUT4 vesicles
Rat adipocytes at 40% cytocrit were stimulated with 5 nM insulin for 20
min at 37°C. In a typical experiment 10 ml of cells were used. After cooling
the cells to 18°C the surface GLUT4 was labeled with 500 M biotinylated
photolabel GP15 (Hashimoto et al., 2001) and incubated with 10 g/ml of
cells DyLight647 streptavidin for a further 15 min. Insulin was removed and
GLUT4 was internalized (Yang et al., 2002b). The cells were then homoge-
nized and processed as described previously (Simpson et al., 1983) to ob-
tain a post-high-density-microsome supernatant, containing the fluores-
cently tagged GLUT4 vesicles. The GLUT4 vesicles were purified by
immunoisolation using an anti-GLUT4 antibody (Satoh et al., 1993) pre-
bound to the MBP-pa construct attached to a 0.7 ml amylose resin column.
After 2 hr incubation, the column was washed with Intracellular Buffer (IC
buffer: 20 mM HEPES [pH 7.4], 140 mM potassium glutamate, 5 mM NaCl,
1 mM EGTA) and the GLUT4 vesicles were eluted in 500 l fractions with
20 mM maltose in IC buffer. The presence of GLUT4 in each fraction was
monitored by measuring the DyLight 647 fluorescence. Usually, fractions
1–3 were pooled together and used as a source of purified GLUT4 vesicles.
GLUT4 in the fractions was analyzed after the experiments and using a
sheep anti-GLUT4 antibody.
Preparation of cytosol and plasma-membrane liposomes
Concentrated cytosol was prepared from rat adipose cells in the basal state
or following treatment with 20 nM insulin for 20 min. Cells were washed
once with buffer without Bovine Serum Albumin and once with IC buffer. As
much buffer as possible was removed and the cells were vortexed and then
spun for 70 min at 265000 xg in an Optima MAX ultracentrifuge. The cytosol
was recovered between the pellet of crude membranes at the bottom andCELL METABOLISM : SEPTEMBER 2005
In vitro GLUT4 vesicle fusionthe fat layer at the top and kept frozen at −70°C until further needed. To
immunodeplete the Akt content of the cytosol, fresh cytosol was incubated
overnight with anti-Akt1 antibody clone 5G3 (Cell Signaling Technology)
alone or in combination with anti-Akt2 antibody clone AW114 (Upstate). The
antibodies were removed with immobilized ProteinA/G. The cytosol was
analyzed to assess the amount of depletion prior to use in the fusion assay.
Basal and insulin-stimulated plasma membranes were prepared (Simp-
son et al., 1983) and reconstituted in phospholipid liposomes using an
adaptation of previously described methods (Kono, 1983; Schurmann et al.,
1989). Purified plasma membrane was solubilized in 1.25% n-octyl gluco-
side and applied to Sephadex G50 column. 200 l aliquots of solubilized
eluted protein (300 g/ml) were gently vortex mixed with 40 l of 150 mg/
ml Soya bean phosphatidylcholine (Type IV-S Sigma) in 20 mM HEPES (pH
7.4). A biotin-Europium (TMT) ligand (Figure 1B) was added at 55 nM final
concentration and the mixture was sonicated for 15 s and frozen to −70°C
for at least 2 hr. The samples were then thawed, resonicated and purified
on flotation Histodenz gradients (Weber et al., 1998). The liposomes were
mixed 1:1 with 80% Histodenz in reconstitution buffer (25 mM HEPES, pH
7.4, 100 mM KCl, 1 mM DTT) containing 10% glycerol. This was overlayed
with 30% Histodenz in reconstitution buffer, with glycerol, and then with
buffer only. After an 11 hr, 40 min spin at 35,000 rpm in a SW41Ti rotor,
liposomes were collected at the 0/30% Histodenz interface. The amount of
encapsulated biotin-Eu(TMT) was monitored by measuring the fluorescence
against a standard curve. Typically 1–2 nM of Biotin-Eu(TMT) was encapsu-
lated in 1 ml of isolated liposomes.
Fusion assays
Fusion assays were performed in duplicate. 50 µl of GLUT4 vesicles, lipo-
somes and cytosol were mixed with 25 µl of IC buffer containing 1 µM
biocytin on ice. Fusion was initiated by adding 50 µl of ATP regenerating
system (final concentration: 1 mM ATP, 5 mM MgCl2, 8 mM phosphocre-
atine, and 31 U/ml creatine phosphokinase Type 1) at 37°C. In some cases
GLUT4 vesicles and PM liposomes were mixed with the ATP regenerating
system on ice and the reaction was initiated by adding cytosol. Fusion was
stopped by returning the samples on ice and addition of 1% triton-X100
containing excess biocytin. The extent to which fusion had occurred prior
to this endpoint was detected by TR-FRET between Europium(TMT) and
DyLight 647 in a FARCyte microplate reader. The TR-FRET signal was cal-
culated from the ratio of the emission at 670 nm/612 nm with excitation at
340 nm. The zero time point was used as a measure of the background
and was subtracted from each value. Generally the extent of fusion at 5
min was compared with the maximal fusion obtained by incubation at 37°C
for 30 min. The time-resolved lag times and integration times used are in
Figure S1, together with typical fluorescence output. All attempts to monitor
fusion activity in real time were unsuccessful.
Detection of Akt recruitment and phosphorylation
Plasma-membrane liposomes were mixed with equal volumes of rat adipocyte
cytosol, IC buffer and ATP regeneration system on ice. After a 15 min incuba-
tion at 37°C the samples were recooled on ice and diluted with an equal vol-
ume of 20 mM HEPES [pH 7.4], 150 mM NaCl buffer containing 1 mM Na-
molybdate, 100 mM NaF, 1 mM Na-orthovanadate and 100 nM okadaic acid.
The samples were spun at 540000 gmax for 20 min in an Optima MAX ultra-
centrifuge to separate the liposomes from the cytosol. The pellet (liposomes)
and the supernatant (cytosol) were separately analyzed by Western blotting
with anti-Akt1, anti-Akt2, and anti-phosphoThr308 Akt antibodies.
Glucose transport and GLUT4 exocytosis
Rates of 3-O-methyl-D-glucose transport in isolated adipocytes were deter-
mined as described (Satoh et al., 1993). The substrate concentration was
50 µM and uptake was determined for 3 s. GLUT4 exocytosis rates were
determined as described (Yang et al., 2002b; Yang and Holman, 2004). The
procedure involved internalisation of GP15 biotin-tagged GLUT4 followed
by restimulation of exocytosis. The GLUT4 that then reemerged at the cell
surface was quenched by extracellular avidin. The GLUT4 that remained
inside the cell was then precipitated with immobilized streptavidin and then
detected by Western blotting with a GLUT4 C-terminal peptide antibody.CELL METABOLISM : SEPTEMBER 2005Supplemental data
Supplemental Data include one figure and can be found with this article
online at http://www.cellmetabolism.org/cgi/content/full/2/3/179/DC1/.
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